Where you live, walk, and eat in New York City are important for controlling diabetes

April 02, 2018

April 2, 2018 -- In the first study to directly examine the relationship between environment and individual's ability to control their diabetes, researchers at Columbia University's Mailman School of Public Health and the New York City Department of Health and Mental Hygiene found there is a link between the neighborhood food, built and economic environment where you live and the ability to achieve glycemic control. Their results are consistent with the premise that areas with greater resources to support healthy eating and physical activity, and a high socioeconomic environment are associated with improved glycemic control in persons with diabetes. The results are published today in the American Journal of Epidemiology.

The odds of individuals achieving glycemic control in the most advantaged residential neighborhoods were two and a half times greater than in the least advantaged. Furthermore, individuals who lived in the most advantaged residential neighborhoods achieved glycemic control in a shorter period of time (14 percent shorter) than individuals who lived in the least advantaged neighborhoods.

"Our study is the first to look at a wide range of built and economic features of a residential environment and how they may affect a person's ability to control their diabetes," said Andrew Rundle, DrPH, associate professor of Epidemiology at the Mailman School of Public Health. "And until now, no study had evaluated whether these cumulative exposures were associated with glycemic control in a large multiracial, multiethnic population."

The researchers analyzed multiple hemoglobin A1C measurements through time from 182,756 New York City adults with diabetes over a 7-year period. Reductions in A1C levels through time, to below 7 percent, indicated that a diabetic had achieved glycemic control. Living in neighborhoods with more advantaged socioeconomic conditions, greater ratio of healthy food outlets to unhealthy food outlets, and higher neighborhood walkability were associated with achieving glycemic control.

Individuals who lived continuously in more advantaged residential areas with high quality environment resources had lower average A1C values and better control of their diabetes compared to the individuals who lived continuously in less advantaged residential areas with low quality environment resources. Moving from less advantaged residential areas to more advantaged residential areas was related to improved diabetes control, while moving from more advantaged residential areas to less advantaged residential areas was related to worsening diabetes control.

In 2006, the New York City Department of Health and Mental Hygiene implemented mandatory reporting of hemoglobin A1C tests to the A1C Registry, which enabled public health surveillance of diabetes trends in New York City. Consistent with the American Diabetes Association's diagnostic criteria, diabetes was defined as at least two A1C tests with a value of greater or equal to 6.5 percent since the Registry was launched. NYC residents with diabetes 18 years of age and older who had at least one A1C test every year in the Registry between January 2007 and December 31, 2013 were included in the study. 

"It is possible also, that the environments around where a person works may also affect their ability to achieve glycemic control," said Rundle. "However, since the A1C registry does not include information on work locations we were not able to test this idea with these data."
Bahman P. Tabaei, with the New York City Department of Health and Mental Hygiene, is a co-principal investigator. Co-authors are Winfred Y. Wu and Shadi Chamany, New York City Department of Health and Mental Hygiene, Daniel M. Sheehan, Mailman School of Public Health, Carol R. Horowitz and Victoria Maye, Icahn School of Medicine at Mt. Sinai.

The authors report no financial conflict of interest.

Columbia University's Mailman School of Public Health

Founded in 1922, Columbia University's Mailman School of Public Health pursues an agenda of research, education, and service to address the critical and complex public health issues affecting New Yorkers, the nation and the world. The Mailman School is the third largest recipient of NIH grants among schools of public health. Its over 450 multi-disciplinary faculty members work in more than 100 countries around the world, addressing such issues as preventing infectious and chronic diseases, environmental health, maternal and child health, health policy, climate change & health, and public health preparedness. It is a leader in public health education with over 1,300 graduate students from more than 40 nations pursuing a variety of master's and doctoral degree programs. The Mailman School is also home to numerous world-renowned research centers including ICAP and the Center for Infection and Immunity. For more information, please visit http://www.mailman.columbia.edu.

Columbia University's Mailman School of Public Health

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.